Document Type : Original Article(s)
Authors
- Hamidreza Mohammadi 1
- Mohammad Shokrzadeh 1
- Omid Akbari-Dafsari 1
- Nahid Amani 1
- Mona Modanlou 1
- Abbas Mohammadpour 1
- Majid Jafari-Sabet 2
- Ramin Ataee 1, 3
1 Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari Iran
2 Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran Iran
3 Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari Iran
Abstract
Background: Curcumin is a natural polyphenolic material with antioxidative, anti-inflammatory, and anticancer effects. In this study, we attempted to assay antiproliferative and apoptotic properties of polymeric micelles of curcumin on two colorectal cancer cell lines and normal human fibroblast cells.
Method: In this experimental study, cancer cells HT29, HCT116 and normal human fibroblast cells (HGF) were subjected to concentrations of Nano- curcumin (1, 50, 100, 250, and 500 μg/ml). After incubation for 48 hours, cell viability was assessed with "MTT"(3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay. Annexin V-FITC and Propidium iodide staining were done with flow cytometry for evaluation of apoptosis. The results were shown as mean ± standard deviation. Statistical significance was assessed utilizing ANOVA and Dunnetts t-test (P < 0.01).
Results: According to MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay results, IC50 value of Nano- curcumin in HT29, HCT116, and HGF were 70.63, 123.9, and 168.53 μg/ml, respectively. We also discovered that Nano-curcumin can make indicative apoptosis in cancer cells, which could be compared with cisplatin <0.01.
Conclusion: These results revealed remarkable antiproliferative and apoptotic effects of polymeric Nano-micelles of curcumin in colorectal cancer cell lines.
Keywords
How to cite this article:
Mohammadi H, Shokrzadeh M, Akbari-Dafsari O, Amani N, Modanlou M, Mohammadpour A, et al. Evaluation of curcumin nano-micelle on proliferation and apoptosis of HT29 and Hct116 colon cancer cell lines. Middle East J Cancer. 2022;13(1):99-109. doi: 10.30476/ mejc.2021.87699. 1429.
2.Alinezhad V, Alinezhad H, Ataee R, Ataie A. Utilization of curcumine and nanocurcumine compounds in cancer therapy. Pharm Biomed Res. 2017;3(3):1-11. doi:10. 29252/pbr.3.3.1.
3.Zhan Y, Chen Y, Liu R, Zhang H, Zhang Y. Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling. Arch Pharm Res. 2014;37(8):1086-95. doi: 10.1007/s12272-013-0311-3.
4.Sun XD, Liu XE, Huang DS. Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression. Mol Med Rep. 2012; 6(6):1267-70. doi: 10.3892/mmr.2012.1103.
5.Ataie A, Shadifar M, Ataee R. Polyphenolic antioxidants and neuronal regeneration. Basic Clin Neurosci. 2016;7(2):81-90. doi: 10.15412/J.BCN. 03070201.
6.Chakraborty J, Banerjee S, Ray P, Hossain DM, Bhattacharyya S, Adhikary A, et al. Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cells. J Biol Chem. 2010;285(43):33104-12. doi: 10.1074/jbc.M110. 122705.
7.Hasima N, Ozpolat B. Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell Death Dis. 2014;5(11):e1509. doi: 10.1038/cddis.2014.467.
8.Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, et al. Anti-cancer natural products isolated from chinese medicinal herbs. Chin Med. 2011;6(1):27. doi: 10.1186/1749-8546-6-27.
9.Lee JH, Chung IK. Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT. Cancer Lett. 2010;290(1):76-86. doi: 10.1016/j.canlet.2009.08.026.
10.Ataee R, Shokrzadeh M, Asgari R, Hasanzadeh R, Abediankenari S, Asgarian Emran H. Evaluation of anti-proliferative and apoptotic effect of resveratrol on ags cell line of gastric adenocarcinoma. [In Persian] J Urm Univ of Med Sci. 2016;27(8):661-70.
11. Jafari A, Teymouri M, Ebrahimi Nik M, Abbasi A, Iranshahi M, Hanafi-Bojd MY, et al. Interactive anticancer effect of nanomicellar curcumin and galbanic acid combination therapy with some common chemotherapeutics in colon carcinoma cells. Avicenna J Phytomed. 2019;9(3):237-47.
12.Kazemi-Lomedasht F, Rami A, Zarghami N. Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv Pharm Bull. 2013;3(1):127-30. doi: 10.5681/apb. 2013.021.
13.Byun SY, Kim DB, Kim E. Curcumin ameliorates the tumor-enhancing effects of a high-protein diet in an azoxymethane-induced mouse model of colon carcinogenesis. Nutr Res. 2015;35(8):726-35. doi: 10.1016/j.nutres.2015.05.016.
14.Wei SC, Lin YS, Tsao PN, Wu-Tsai JJ, Wu CH, Wong JM. Comparison of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib, curcumin, and nifedipine in mismatch repair-deficient cell lines. J Formos Med Assoc. 2004;103(8):599-606.
15.Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J Phytomed. 2016;6(4):383-98.
16.Fang XB, Zhang JM, Xie X, Liu D, He CW, Wan JB, et al. pH-sensitive micelles based on acid-labile pluronic F68-curcumin conjugates for improved tumor intracellular drug delivery. Int J Pharm. 2016;502(1-2):28-37. doi: 10.1016/j.ijpharm.2016.01.029.
17.Li M, Gao M, Fu Y, Chen C, Meng X, Fan A, et al. Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery. Colloids Surf B Biointerfaces. 2016;140:11-8. doi: 10.1016/j.colsurfb.2015.12.025.
18.Gou M, Men K, Shi H, Xiang M, Zhang J, Song J, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 2011;3(4):1558-67. doi: 10.1039/c0nr 00758g.
19.Sarbolouki MN, Alizadeh AM, Khaniki M, Azizian S, Mohaghgheghi MA. Protective effect of dendrosomal curcumin combination on colon cancer in rat.[In Persian] Tehran Univ Med J. 2012;69(11):678-85.
)